The unresolved problem of beta-2 microglobulin amyloid deposits in the intervertebral discs of long-term dialysis

Tsung-Ting Tsai1, Arun-Kumar Kaliya-Perumal2,3, Chang-Chyi Jenq4

  • 1Department of Orthopaedic Surgery, Spine Division, Bone and Joint Research Center, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan, Taiwan. tsai1129@gmail.com.

Abstract

Insights

Beta-2 microglobulin (β2M) amyloid deposits increase in intervertebral discs of long-term dialysis patients. This accumulation correlates with dialysis duration, indicating current dialysis methods are insufficient for β2M removal.

Area of Science:

  • Nephrology
  • Orthopedics
  • Pathology

Background:

  • Dialysis-related destructive spondyloarthropathy is a significant complication for long-term dialysis patients.
  • This condition is characterized by beta-2 microglobulin (β2M) amyloid deposits in intervertebral discs.
  • Current dialysis membranes may not effectively remove β2M.

Purpose of the Study:

  • To quantify β2M amyloid deposits in the intervertebral disc tissue of long-term dialysis patients.
  • To analyze the correlation between β2M accumulation and dialysis duration.

Main Methods:

  • Histological analysis, including immunohistochemistry (IHC) and Congo red staining, was performed on intervertebral disc tissue.
  • Two groups were studied: 29 long-term dialysis patients and 10 controls with no renal impairment.
  • Tissue sections were obtained during spinal surgery for degenerative spinal pathologies.

Main Results:

  • A statistically significant increase in β2M expression was observed in the disc tissue of long-term dialysis patients compared to controls.
  • Both IHC and Congo red staining showed significantly higher β2M levels in the dialysis group (p=0.012 and p=0.047, respectively).
  • A moderate positive correlation was found between dialysis duration and β2M deposition (r=0.39 for IHC, r=0.42 for Congo red).

Conclusions:

  • β2M amyloidosis in long-term dialysis patients is a persistent issue, even with high-flux membranes.
  • Existing dialysis modalities appear insufficient for effective β2M filtration.
  • Further research into improved dialysis strategies is warranted to address β2M-related complications.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.1K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
256
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.0K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
492
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
705
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.0K